(Reuters) -German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk ...

While the companies did not reveal the financial details of the deal, Novo Nordisk will provide funding for two Evotec sites ...

Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial ...

Evotec has entered a partnership with Novo Nordisk to develop next-generation off-the-shelf cell therapy technologies. Novo ...

Evotec and Novo Nordisk are collaborating on next-gen cell therapy, focusing on scalable, stem cell-based solutions. Novo Nordisk will fund development at Evotec’s R&D facilities, with Evotec ...

Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.

Shares of Evotec (ETR: EVTG)rose on Thursday after the company said it has entered a technology development partnership with ...

German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...

Hamburg, Germany, 26 September 2024: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Evotec has entered a technology development ...

Sept 26 (Reuters) - German drug and development company Evotec (EVTG.DE), opens new tab has entered into a technology development partnership with Novo Nordisk (NOVOb.CO), opens new tab to support ...

Evotec SE, a life science company, has entered a technology development partnership with Novo Nordisk in cell therapy. Both Evotec and Novo Nordisk have significant expertise and a strategic focus to ...

(Reuters) - German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support clinical and commercial manufacturing of stem cell-based ...